Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
23.36
-0.56 (-2.34%)
At close: Mar 6, 2026, 4:00 PM EST
22.73
-0.63 (-2.69%)
After-hours: Mar 6, 2026, 7:01 PM EST
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Elanco Animal Health stock have an average target of 27.63, with a low estimate of 23 and a high estimate of 30. The average target predicts an increase of 18.28% from the current stock price of 23.36.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 5 | 6 | 7 | 7 | 6 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +2.74% | Feb 25, 2026 |
| Keybanc | Keybanc | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +24.14% | Feb 25, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +28.42% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $24 → $28 | Buy | Maintains | $24 → $28 | +19.86% | Feb 19, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $24 → $30 | Hold → Buy | Upgrades | $24 → $30 | +28.42% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
5.09B
from 4.72B
Increased by 7.97%
Revenue Next Year
5.36B
from 5.09B
Increased by 5.21%
EPS This Year
1.05
from -0.47
EPS Next Year
1.18
from 1.05
Increased by 12.42%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.3B | 5.6B | |||
| Avg | 5.1B | 5.4B | |||
| Low | 4.8B | 5.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.7% | 9.9% | |||
| Avg | 8.0% | 5.2% | |||
| Low | 1.8% | -2.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.17 | 1.32 | |||
| Avg | 1.05 | 1.18 | |||
| Low | 0.97 | 1.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 25.8% | |||
| Avg | - | 12.4% | |||
| Low | - | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.